A Phase II Trial of Panobinostat, a Histone Deacetylase Inhibitor, in the Treatment of Patients with Refractory Metastatic Renal Cell Carcinoma. - Hainsworth JD; Infante JR; Spigel DR; Arrowsmith ER; Boccia RV; Burris HA (Cancer Investigation, 2011)